Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Akagi

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
Anticancer Research|July 27, 2023
Development of an Algorithm to Predict Recurrences After Resection of Liver Metastases in Patients With Metastatic Colorectal CancerMitsuhiro Katagiri, Tomoya Sudo, Tatsuyuki Tounann, et al.
Journal of Cellular Biochemistry|February 24, 2012
Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathwaysNaoko Seki, Uhi Toh, Koji Kawaguchi, et al.
Oncology|February 9, 2013
Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701)Eiji Oki, Yasunori Emi, Yoshito Akagi, et al.
BMC Cancer|January 6, 2021
Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)Keisuke Miwa, Eiji Oki, Masanobu Enomoto, et al.
Anticancer Research|June 30, 2016
Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal CancerSachiko Shiraiwa, Tetsushi Kinugasa, Akihiko Kawahara, et al.
The Kurume Medical Journal|August 14, 2019
Questionnaire Survey from the 1st Kurume University Inflammatory Bowel Disease Center Educational LectureHiroshi Yamasaki, Tetsushi Kinugasa, Shoko Iwasaki, et al.
International Journal of Clinical Oncology|September 5, 2015
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)Yutaka Ogata, Mototsugu Shimokawa, Takaho Tanaka, et al.
The Kurume Medical Journal|February 8, 2023
Effectiveness of the Gerdq Questionnaire for Diagnosing Gastroesophageal Reflux Disease After Esophagectomy for Esophageal CancerKohei Saisho, Naoki Mori, Toshiaki Tanaka, et al.
BMC Surgery|March 9, 2021
Laparoscopic left hepatectomy for a patient with intrahepatic cholangiocarcinoma metastasis in the falciform ligament: a case reportYoriko Nomura, Hisamune Sakai, Jun Akiba, et al.
Breast Cancer Research : BCR|July 5, 2014
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patientsRyuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Anticancer Research|July 27, 2023
Development of an Algorithm to Predict Recurrences After Resection of Liver Metastases in Patients With Metastatic Colorectal CancerMitsuhiro Katagiri, Tomoya Sudo, Tatsuyuki Tounann, et al.
Journal of Cellular Biochemistry|February 24, 2012
Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathwaysNaoko Seki, Uhi Toh, Koji Kawaguchi, et al.
Oncology|February 9, 2013
Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701)Eiji Oki, Yasunori Emi, Yoshito Akagi, et al.
BMC Cancer|January 6, 2021
Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)Keisuke Miwa, Eiji Oki, Masanobu Enomoto, et al.
Anticancer Research|June 30, 2016
Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal CancerSachiko Shiraiwa, Tetsushi Kinugasa, Akihiko Kawahara, et al.
The Kurume Medical Journal|August 14, 2019
Questionnaire Survey from the 1st Kurume University Inflammatory Bowel Disease Center Educational LectureHiroshi Yamasaki, Tetsushi Kinugasa, Shoko Iwasaki, et al.
International Journal of Clinical Oncology|September 5, 2015
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)Yutaka Ogata, Mototsugu Shimokawa, Takaho Tanaka, et al.
The Kurume Medical Journal|February 8, 2023
Effectiveness of the Gerdq Questionnaire for Diagnosing Gastroesophageal Reflux Disease After Esophagectomy for Esophageal CancerKohei Saisho, Naoki Mori, Toshiaki Tanaka, et al.
BMC Surgery|March 9, 2021
Laparoscopic left hepatectomy for a patient with intrahepatic cholangiocarcinoma metastasis in the falciform ligament: a case reportYoriko Nomura, Hisamune Sakai, Jun Akiba, et al.
Breast Cancer Research : BCR|July 5, 2014
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patientsRyuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Pageof 27